The Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization one year ago overturned 50 years of legal precedent protecting the constitutional right to abortion in the United States, leaving the question of...more
Renewed interest in the potential benefits of psychedelic treatments has led to an upsurge in research. Is the first FDA approval of a psychedelic for therapeutic use on the horizon?
On this episode, Epstein Becker Green...more
The U.S. Food and Drug Administration (FDA) recently issued a final guidance document clarifying how the agency intends to regulate clinical decision support (CDS) software.
How has this document caused confusion for...more
In the aftermath of the Dobbs v. Jackson Women’s Health Organization decision, important questions have emerged about the current legal and regulatory landscape surrounding patient access to drugs that have historically been...more
Although the COVID-19 pandemic exposed cybersecurity vulnerabilities across sectors, it has particularly challenged the resilience of information systems for health care and life sciences companies. Because ransomware attacks...more
The vaccine passport has been a major topic of discussion as businesses and governments consider how to balance privacy and safety through the rollout of the COVID-19 vaccine. Epstein Becker Green attorneys Patricia Wagner,...more
The legal history of the current immunization delivery system for vaccines in the United States is complex and requires the coordination of many players, from manufacturers and distributors in the supply chain to health care...more
Contact tracing will continue to play a big role in fighting the COVID-19 pandemic, especially in understanding the impact of vaccines. Attorneys Michelle Capezza, Karen Mandelbaum, and Jessika Tuazon look at the privacy...more
12/8/2020
/ Contact Tracing ,
Coronavirus/COVID-19 ,
Data Privacy ,
Data Security ,
Employee Privacy Rights ,
Employment Policies ,
Health and Safety ,
Health Care Providers ,
Healthcare Workers ,
Infectious Diseases ,
Public Health ,
Public Safety ,
Virus Testing
This Diagnosing Health Care episode looks at the adjustments to business operations and compliance programs that pharmaceutical and medical device companies need to consider as they launch new products during the ongoing...more
9/29/2020
/ Clinical Trials ,
Coronavirus/COVID-19 ,
Health Care Providers ,
Life Sciences ,
Manufacturer Liability ,
Medical Devices ,
Medical Supplies ,
Pharmaceutical Industry ,
Physicians ,
Prescription Drugs ,
Product Development Protocols ,
Research and Development
In this Thought Leaders in Health Law® video, attorneys Neil Di Spirito, Alaap Shah, Jessika Tuazon, and Patricia Wagner from Epstein Becker Green look at the Food and Drug Administration’s (FDA’s) guidance on the...more